24 results
Irritable Bowel Syndrome (IBS) in Pregnancy
 - Pathophysiology
 - Pharmacotherapy
 - Nonpharmacological Treatment

Emory Gastroenterology and Hepatology
Bowel Syndrome (IBS ... Nonpharmacological Treatment ... Emory Gastroenterology ... and Hepatology ... Bowel #Syndrome #IBS
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
Here is a quick ... DAAs #Antivirals #table ... #treatment #hcv ... infectiousdisease #hepatology
Irritable Bowel Syndrome (IBS) - Management
Global IBS Symptoms:
  - Limited trial low FODMAP diet
Bowel Syndrome (IBS ... TinaPhamHang via Emory Gastroenterology ... and Hepatology ... Syndrome #Management #gastroenterology ... #treatment
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
cell transplant is ... only curative treatment ... Diagnosis #Management #treatment ... #hematology #oncology
Thrombotic Microangiopathy - TTP VS HUS

Big picture points : Often hard to differentiate the two entities,
distinction has HUGE treatment ... and first-line treatment ... is plasma exchange ... Comparison #Diagnosis #Table ... #Hematology
Irritable Bowel Syndrome (IBS) - Diagnosis and Management Summary
Diagnosis:
 • Use a positive diagnostic strategy with
for diagnosis Treatment ... TinaPhamHang via Emory Gastroenterology ... and Hepatology ... Diagnosis #Management #gastroenterology ... #treatment
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... **Edoxaban is initiated ... ¥LMWH is currently ... Anticoagulation #Management #Hematology ... #Oncology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
usual INR target is ... therapeutic range) is ... #pharmacology #treatment ... #medications #table ... decisionaid #cardiology #hematology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... P-glycoprotein is ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology
Systemic Therapy for Hepatocellular Carcinoma - AGA Clinical Practice Guideline

First Line Treatment for HCC with Preserved
First Line Treatment ... Function Second Line Treatment ... #Management #Hepatology ... #Gastroenterology ... #oncology #Pharmacology